This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.


Update on Legal Issues Associated With Tardive Dyskinesia

Ralph Slovenko, JD, PhD

Published: April 30, 2000

Article Abstract

Of the various drug therapies, antipsychotic medication presents some novel twists to old issues inlaw and psychiatry. From what is known, its benefits are high but so are its risks, notably the risk oftardive dyskinesia in the case of the neuroleptics. Presented here for consideration are legal issuesof standard of care, informed consent, the right of institutionalized patients to refuse treatment, statuteof limitations, and causal nexus.

Some JCP and PCC articles are available in PDF format only. Please click the PDF link at the top of this page to access the full text.

Related Articles

Volume: 61

Quick Links: Neurologic and Neurocognitive , Neurology

Sign-up to stay
up-to-date today!


Already registered? Sign In

Case Report

Safety and Tolerability of Concomitant Intranasal Esketamine Treatment With Irreversible, Nonselective MAOIs: A Case Series

Three cases suggest that concomitant use of intranasal esketamine with an irreversible, nonselective MAOI is safe in...